| Pharmaceutical active ingredients: |
| Tolbutamide |
| Available forms, composition and doses of Ipoglusan: |
| N / A |
| Ipoglusan medical category: |
| Human:Antidiabetic agents (type II diabetes)Potassium channel blockers first generationSulfonylurea group drugs |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| A10BB03 - TolbutamideV04CA01 - Tolbutamide |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Bioquimico Mexicano Laboratorios |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Ipodex | Dexamethasone Sodium Phosphate; Neomycin Sulfate; Polymyxin B Sulfate | Medilife Pharma; I-Senz Pharma |
| Ipodex-CV | Cefpodoxime; Clavulanic Acid | Intra Labs India |
| Ipod-Kid | Cefpodoxime Proxetil | Invision Medi Sciences |
| Ipogen | Chlorothiazide; Dihydralazine Tartrate | Gentili Istituto |
| Ipoglicone | Tolbutamide | Unidentified Pharmaceutical Company |
| Ipogras | Sibutramine | Chile Laboratorios |
| Ipol | Poliomyelitis Vaccine inactivated | Sanofi-Aventis; Merck |
| Ipolab | Labetalol Hydrochloride | Finmedical |
| Ipolina | Hydralazine Hydrochloride | Reggiano Laboratorio Farmaceutico |
| Ipolipid | Gemfibrozil | Medochemie; Derek Marketing; Komedic; Medline, Thailand; Star Medical Supplies |